Description
Mounjaro KwikPen 7.5 mg is a prescription-only injectable medicine containing tirzepatide as its active ingredient. It is supplied in a pre-filled, multi-dose pen designed for convenient once-weekly subcutaneous administration.
Tirzepatide works by activating GIP and GLP-1 receptors, which help regulate blood glucose levels, appetite, and food intake. When used alongside a balanced diet and regular physical activity, Mounjaro can help improve blood sugar control in adults with type 2 diabetes. It is also indicated for weight management in eligible patients, in accordance with local prescribing guidelines.
The 7.5 mg strength may be prescribed as part of a gradual dose-escalation schedule, depending on the patient’s individual needs, treatment response, and tolerability. Treatment should always be adjusted under the supervision of a qualified healthcare professional.
Product Features:
- Brand: Mounjaro
- Product: KwikPen 7.5 mg
- Active ingredient: Tirzepatide
- Strength: 7.5 mg per dose
- Administration: Subcutaneous injection
- Dosage frequency: Once weekly
- Packaging: Pre-filled, multi-dose injection pen
- Availability: Prescription only
Important Safety Information:
Patients should discuss their medical history, current medications, and any potential risks with their healthcare provider before starting treatment.
Storage: Store and handle the product according to the instructions in the official patient information leaflet. Keep out of the reach of children.
Reviews
There are no reviews yet.